This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignees: Fondazione Istituto Italiano Di Tecnologia, Università Degli Studi Di Roma "La Sapienza". Active years: 2021.
Company Filing History:
1 out of 146 
1 out of 63 
Years Active: 2021
Title: Francesca Giulimondi: Innovator in Cancer Treatment
Introduction
Francesca Giulimondi is a prominent inventor based in Rome, Italy. She has made significant contributions to the field of oncology, particularly in the treatment of T-cell acute lymphoblastic leukemia (T-ALL). Her innovative work has the potential to impact the lives of many patients suffering from this aggressive form of cancer.
Latest Patents
Francesca holds a patent for "Notch inhibitors for use in the treatment of T-cell acute lymphoblastic leukemia." This patent describes compounds of formula (I) that exhibit anti-tumor activity, specifically targeting T-ALL. Her research in this area is crucial for developing new therapeutic strategies.
Career Highlights
Throughout her career, Francesca has worked with esteemed institutions such as Università Degli Studi Di Roma "La Sapienza" and Fondazione Istituto Italiano Di Tecnologia. Her dedication to research and innovation has established her as a key figure in her field.
Collaborations
Francesca has collaborated with notable colleagues, including Bruno Botta and Cinzia Ingallina. These partnerships have enhanced her research efforts and contributed to her success in developing effective treatments.
Conclusion
Francesca Giulimondi's work exemplifies the vital role of inventors in advancing medical science. Her contributions to cancer treatment through innovative patents highlight the importance of research and collaboration in the fight against disease.